Prot # 1160.129: Boehringer Ingelheim Pharmaceuticals, Inc., “GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation” (Phase II/III)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/29/12 → 3/29/20

Funding

  • Covance Inc. (Prot # 1160.129 // Prot # 1160.129)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot # 1160.129 // Prot # 1160.129)